
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Description
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
HIV Point of care (POC) Tests is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results are used for clinical decision making. POC has a range of complexity and procedures that vary from manual methodologies to automated analyzers. POC devices are often ‘handheld’ or may be small portable analyzers.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the HIV Point of care (POC) Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
107 Pages
- 1 About GlobalData
- 2 Table of Contents
- 2.1 List of Tables
- 2.2 List of Figures
- 3 Introduction
- 3.1 HIV Point of care (POC) Tests Overview
- 4 Products under Development
- 4.1 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
- 4.2 HIV Point of care (POC) Tests - Pipeline Products by Territory
- 4.3 HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
- 4.4 HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
- 4.5 HIV Point of care (POC) Tests - Ongoing Clinical Trials
- 5 HIV Point of care (POC) Tests - Pipeline Products under Development by Companies
- 5.1 HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
- 5.2 HIV Point of care (POC) Tests – Companies Pipeline Products by Stage of Development
- 6 HIV Point of care (POC) Tests Companies and Product Overview
- 6.1 Abbott Rapid Diagnostics GmbH Company Overview
- 6.1.1 Abbott Rapid Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 6.2 Aldatu Biosciences Inc Company Overview
- 6.2.1 Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.3 Altratech Ltd Company Overview
- 6.3.1 Altratech Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.4 Atomo Diagnostics Ltd Company Overview
- 6.4.1 Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.5 Baebies Inc Company Overview
- 6.5.1 Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.6 BBB Technologies Inc Company Overview
- 6.6.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.7 Beijing Wantai Biological Pharmacy Enterprise Co Ltd Company Overview
- 6.7.1 Beijing Wantai Biological Pharmacy Enterprise Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.8 Binx Health Inc Company Overview
- 6.8.1 Binx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.9 Bio-AMD Inc Company Overview
- 6.9.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.1 Biocartis Group NV Company Overview
- 6.10.1 Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
- 6.11 BioHelix Corp Company Overview
- 6.11.1 BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.12 Bluejay Diagnostics Inc Company Overview
- 6.12.1 Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.13 Calypte Biomedical Corporation Company Overview
- 6.13.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
- 6.14 Centre International de Reference Chantal Biya Company Overview
- 6.14.1 Centre International de Reference Chantal Biya Pipeline Products & Ongoing Clinical Trials Overview
- 6.15 Cepheid Inc Company Overview
- 6.15.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.16 ChipCare Corp Company Overview
- 6.16.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.17 CrossLife Technologies Inc Company Overview
- 6.17.1 CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.18 Cue Inc Company Overview
- 6.18.1 Cue Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.19 Daktari Diagnostics, Inc. Company Overview
- 6.19.1 Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 6.2 Diagnostics For All Inc Company Overview
- 6.20.1 Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.21 Diagnostics for the Real World (Europe) Ltd Company Overview
- 6.21.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.22 Endeavor Sciences Inc Company Overview
- 6.22.1 Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.23 Epinex Diagnostics Inc Company Overview
- 6.23.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.24 ERBA Molecular Ltd Company Overview
- 6.24.1 ERBA Molecular Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.25 Fluxergy LLC Company Overview
- 6.25.1 Fluxergy LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.26 GAIA Medical Institute LLC Company Overview
- 6.26.1 GAIA Medical Institute LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.27 genedrive plc Company Overview
- 6.27.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
- 6.28 Group K Diagnostics Company Overview
- 6.28.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
- 6.29 Guangzhou Wondfo Biotech Co Ltd Company Overview
- 6.29.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.3 HA TECH Pty Ltd Company Overview
- 6.30.1 HA TECH Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.31 HeatFlow Technologies Inc Company Overview
- 6.31.1 HeatFlow Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.32 Identifysensors LLC Company Overview
- 6.32.1 Identifysensors LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.33 Imperial College London Company Overview
- 6.33.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
- 6.34 Integrated Diagnostics Inc (Inactive) Company Overview
- 6.34.1 Integrated Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 6.35 Intuitive Biosciences Inc Company Overview
- 6.35.1 Intuitive Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.36 Jan Biotech Inc Company Overview
- 6.36.1 Jan Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.37 Jinvator Bio Med GmbH Company Overview
- 6.37.1 Jinvator Bio Med GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 6.38 Johns Hopkins University Company Overview
- 6.38.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
- 6.39 Lynntech Inc Company Overview
- 6.39.1 Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.4 Maxim Biomedical Inc Company Overview
- 6.40.1 Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.41 MedMira Inc Company Overview
- 6.41.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.42 Micronics Inc Company Overview
- 6.42.1 Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.43 Molbio Diagnostics Pvt Ltd Company Overview
- 6.43.1 Molbio Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.44 MyMD Pharmaceuticals Inc Company Overview
- 6.44.1 MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.45 Nanobiosym Inc Company Overview
- 6.45.1 Nanobiosym Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.46 Newmark Diagnostics LLC Company Overview
- 6.46.1 Newmark Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
- 6.47 Northwestern University Company Overview
- 6.47.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
- 6.48 Osel Inc Company Overview
- 6.48.1 Osel Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.49 Philmedi Co Ltd Company Overview
- 6.49.1 Philmedi Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.5 Prenetics Ltd Company Overview
- 6.50.1 Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.51 QuantuMDx Group Ltd Company Overview
- 6.51.1 QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.52 Quidel Corp Company Overview
- 6.52.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.53 Radisens Diagnostics Ltd Company Overview
- 6.53.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.54 Rheonix Inc Company Overview
- 6.54.1 Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.55 Roche Diagnostics International Ltd Company Overview
- 6.55.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.56 Sedia Biosciences Corp Company Overview
- 6.56.1 Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview
- 6.57 Sensible Diagnostics Inc Company Overview
- 6.57.1 Sensible Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.58 Senzo Inc Company Overview
- 6.58.1 Senzo Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.59 TheoremDx Inc Company Overview
- 6.59.1 TheoremDx Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.6 Trinity Biotech Plc Company Overview
- 6.60.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
- 6.61 University of Connecticut Company Overview
- 6.61.1 University of Connecticut Pipeline Products & Ongoing Clinical Trials Overview
- 6.62 University of Minnesota Company Overview
- 6.62.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
- 6.63 UrSure Inc Company Overview
- 6.63.1 UrSure Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.64 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview
- 6.64.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 6.65 Virax Biolabs Group Ltd Company Overview
- 6.65.1 Virax Biolabs Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 6.66 Wave 80 Biosciences Inc Company Overview
- 6.66.1 Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- 6.67 Yaathum Biotech Pvt Ltd Company Overview
- 6.67.1 Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 7 HIV Point of care (POC) Tests- Recent Developments
- 7.1 Oct 10, 2023: Trinity Biotech Welcomes the Decision of the High Court of Kenya to Strike Out the Applications to Prevent the Procurement of Trinscreen HIV by the Kenyan Ministry of Health
- 7.2 Sep 27, 2023: Update on MedMira’s Regulatory Path in Canada and the USA
- 7.3 Jun 14, 2023: Atomo and Newfoundland Sign Agreement for HIV Testing in Europe
- 7.4 Mar 22, 2023: Trinity Biotech welcomes TrinScreen HIV’s inclusion in the New Kenyan HIV Testing Algorithm
- 7.5 Feb 28, 2023: Significant purchase order for HIV self-tests for Europe
- 8 Appendix
- 8.1 Methodology
- 8.2 About GlobalData
- 8.3 Contact Us
- 8.4 Disclaimer
- 2.1 List of Tables
- Table 1: HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
- Table 2: HIV Point of care (POC) Tests - Pipeline Products by Territory
- Table 3: HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
- Table 4: HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
- Table 5: HIV Point of care (POC) Tests - Ongoing Clinical Trials
- Table 6: HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
- Table 7: HIV Point of care (POC) Tests – Companies Pipeline Products by Stage of Development
- Table 8: Abbott Rapid Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Table 9: Urine Tenofovir Rapid Assay - Product Status
- Table 10: Urine Tenofovir Rapid Assay - Product Description
- Table 11: Abbott Rapid Diagnostics GmbH - Ongoing Clinical Trials Overview
- Table 12: Urine Tenofovir Rapid Assay - Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
- Table 13: Aldatu Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 14: Pandaa HIV6 - Product Status
- Table 15: Pandaa HIV6 - Product Description
- Table 16: Altratech Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 17: Point-Of-Care Test - HIV Infection - Product Status
- Table 18: Point-Of-Care Test - HIV Infection - Product Description
- Table 19: Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 20: Atomo HIV Self Test - Product Status
- Table 21: Atomo HIV Self Test - Product Description
- Table 22: AtomoRapid HIV - Product Status
- Table 23: AtomoRapid HIV - Product Description
- Table 24: Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 25: Point-of-Care Diagnostic Test - HIV - Product Status(Baebies Inc)
- Table 26: Point-of-Care Diagnostic Test - HIV - Product Description(Baebies Inc)
- Table 27: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 28: Mobile RDT Reader - HIV1/2 Test - Product Status
- Table 29: Mobile RDT Reader - HIV1/2 Test - Product Description
- Table 30: Beijing Wantai Biological Pharmacy Enterprise Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 31: Urine Based Rapid HIV Test - Product Status
- Table 32: Urine Based Rapid HIV Test - Product Description
- Table 33: Binx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 34: Atlas io System - HIV Assay - Product Status
- Table 35: Atlas io System - HIV Assay - Product Description
- Table 36: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 37: Digital Strip Reader - HIV Test - Product Status
- Table 38: Digital Strip Reader - HIV Test - Product Description
- Table 39: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
- Table 40: Idylla Viral Load Assay - HIV - Product Status
- Table 41: Idylla Viral Load Assay - HIV - Product Description
- Table 42: BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 43: IsoAmp HIV-1 Quantitative Assay - Product Status
- Table 44: IsoAmp HIV-1 Quantitative Assay - Product Description
- Table 45: Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 46: HIV POC Test - Product Status
- Table 47: HIV POC Test - Product Description
- Table 48: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
- Table 49: Aware 2 HIV-1/2 - Product Status
- Table 50: Aware 2 HIV-1/2 - Product Description
- Table 51: Centre International de Reference Chantal Biya Pipeline Products & Ongoing Clinical Trials Overview
- Table 52: Point-Of-Care Diagnostic Test - HIV-1 - Product Status
- Table 53: Point-Of-Care Diagnostic Test - HIV-1 - Product Description
- Table 54: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 55: GeneXpert Omni - HIV-1 Qualitative Test - Product Status
- Table 56: GeneXpert Omni - HIV-1 Qualitative Test - Product Description
- Table 57: GeneXpert Omni - HIV-1 Viral Load Test - Product Status
- Table 58: GeneXpert Omni - HIV-1 Viral Load Test - Product Description
- Table 59: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 60: CD4 Assay - HIV - Product Status
- Table 61: CD4 Assay - HIV - Product Description
- Table 62: CrossLife Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 63: TARApen Test - Product Status
- Table 64: TARApen Test - Product Description
- Table 65: Cue Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 66: Cue HIV Viral Load Test - Product Status
- Table 67: Cue HIV Viral Load Test - Product Description
- Table 68: Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 69: Aspect - HIV Viral Load Test - Product Status
- Table 70: Aspect - HIV Viral Load Test - Product Description
- Table 71: Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 72: Paper-Based Microfluidic Device - HIV - Product Status
- Table 73: Paper-Based Microfluidic Device - HIV - Product Description
- Table 74: Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 75: SAMBA - HIV-1 Viral Load Assay - Product Status
- Table 76: SAMBA - HIV-1 Viral Load Assay - Product Description
- Table 77: SAMBA VL - Product Status
- Table 78: SAMBA VL - Product Description
- Table 79: Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 80: Rapid Immunoassay Test - HIV 1 And 2 - Product Status
- Table 81: Rapid Immunoassay Test - HIV 1 And 2 - Product Description
- Table 82: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 83: Epinex G1A - Neo-natal HIV Test - Product Status
- Table 84: Epinex G1A - Neo-natal HIV Test - Product Description
- Table 85: ERBA Molecular Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 86: Next Generation HIV Viral Load Monitoring Test - Product Status
- Table 87: Next Generation HIV Viral Load Monitoring Test - Product Description
- Table 88: Fluxergy LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 89: Diagnostic Test - HIV-1 Viral Load - Product Status
- Table 90: Diagnostic Test - HIV-1 Viral Load - Product Description
- Table 91: GAIA Medical Institute LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 92: Point-Of-Care Diagnostic Test - HIV - Product Status(GAIA Medical Institute LLC)
- Table 93: Point-Of-Care Diagnostic Test - HIV - Product Description(GAIA Medical Institute LLC)
- Table 94: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
- Table 95: Genedrive - HIV Assay - Product Status
- Table 96: Genedrive - HIV Assay - Product Description
- Table 97: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
- Table 98: KromaHealth Kit - HIV Ab/Ag - Product Status
- Table 99: KromaHealth Kit - HIV Ab/Ag - Product Description
- Table 100: Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 101: Accre Diagnostic Assay - HIV Combo - Product Status
- Table 102: Accre Diagnostic Assay - HIV Combo - Product Description
- Table 103: HA TECH Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 104: HIV 1&2 Rapid Antibody Test Kit - Product Status
- Table 105: HIV 1&2 Rapid Antibody Test Kit - Product Description
- Table 106: Human Immunodeficiency Virus Type 1 RT-PCR Detection Kit - Product Status
- Table 107: Human Immunodeficiency Virus Type 1 RT-PCR Detection Kit - Product Description
- Table 108: HeatFlow Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 109: HF-PCR Point Of Care HIV Viral Load Assay - Product Status
- Table 110: HF-PCR Point Of Care HIV Viral Load Assay - Product Description
- Table 111: Identifysensors LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 112: Check4-HIV - Product Status
- Table 113: Check4-HIV - Product Description
- Table 114: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
- Table 115: Diagnostic Assay - HIV - Product Status
- Table 116: Diagnostic Assay - HIV - Product Description
- Table 117: Integrated Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Table 118: HIV Diagnostic Test - Product Status
- Table 119: HIV Diagnostic Test - Product Description
- Table 120: Intuitive Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 121: EV-HIV Assay - Product Status
- Table 122: EV-HIV Assay - Product Description
- Table 123: IRIS-HIV Assay - Product Status
- Table 124: IRIS-HIV Assay - Product Description
- Table 125: Jan Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 126: Point-Of-Care Oral Diagnostic Test - HIV - Product Status
- Table 127: Point-Of-Care Oral Diagnostic Test - HIV - Product Description
- Table 128: Jinvator Bio Med GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Table 129: nanoGold Test - Product Status
- Table 130: nanoGold Test - Product Description
- Table 131: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 6
- Table 132: Point-Of-Care Test - Pediatric HIV - Product Status 6
- Table 133: Point-Of-Care Test - Pediatric HIV - Product Description 6
- Table 134: Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 135: Rapid Point-of-Care HIV Viral Load Test - Product Status
- Table 136: Rapid Point-of-Care HIV Viral Load Test - Product Description
- Table 137: Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 138: Multiplex Lateral Flow Immunoassay - Product Status
- Table 139: Multiplex Lateral Flow Immunoassay - Product Description
- Table 140: MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 141: Reveal G4 Rapid HIV-1 Antibody Test - Product Status
- Table 142: Reveal G4 Rapid HIV-1 Antibody Test - Product Description
- Table 143: Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 144: MTCT - HIV Assay - Product Status
- Table 145: MTCT - HIV Assay - Product Description
- Table 146: PanNAT - HIV Assay - Product Status
- Table 147: PanNAT - HIV Assay - Product Description
- Table 148: Molbio Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 149: Truenat HIV-1/2 Assay - Product Status
- Table 150: Truenat HIV-1/2 Assay - Product Description
- Table 151: MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 152: PIFA HIV 1+2 Rapid Assay - Product Status
- Table 153: PIFA HIV 1+2 Rapid Assay - Product Description
- Table 154: Nanobiosym Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 155: Gene-Radar - HIV Viral Load Assay - Product Status
- Table 156: Gene-Radar - HIV Viral Load Assay - Product Description
- Table 157: Newmark Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 158: Point-Of-Care Diagnostic Test - HIV - Product Status(Newmark Diagnostics LLC)
- Table 159: Point-Of-Care Diagnostic Test - HIV - Product Description(Newmark Diagnostics LLC)
- Table 160: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 6
- Table 161: Infant HIV Test - Product Status 6
- Table 162: Infant HIV Test - Product Description 6
- Table 163: Osel Inc Pipeline Products & Ongoing Clinical Trials Overview 7
- Table 164: Point-Of-Care Diagnostic Test - HIV-1 Infection - Product Status 7
- Table 165: Point-Of-Care Diagnostic Test - HIV-1 Infection - Product Description 7
- Table 166: Philmedi Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 167: HIV POC Molecular Diagnostic Test - Product Status
- Table 168: HIV POC Molecular Diagnostic Test - Product Description
- Table 169: Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 170: -Minute Home Test Kit - HIV - Product Status
- Table 171: -Minute Home Test Kit - HIV - Product Description
- Table 172: QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 173: Q-POC - HIV Assay - Product Status
- Table 174: Q-POC - HIV Assay - Product Description
- Table 175: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 176: Savanna - HIV VL Assay - Product Status
- Table 177: Savanna - HIV VL Assay - Product Description
- Table 178: Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 179: Diagnostic Panel - HIV - Product Status
- Table 180: Diagnostic Panel - HIV - Product Description
- Table 181: Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 182: Rheonix CARD - HIV Assay - Product Status
- Table 183: Rheonix CARD - HIV Assay - Product Description
- Table 184: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 185: Liat HIV-1 Viral Load Assay - Product Status
- Table 186: Liat HIV-1 Viral Load Assay - Product Description
- Table 187: Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 188: Asanté HIV-1/2 Oral Self-Test - Product Status
- Table 189: Asanté HIV-1/2 Oral Self-Test - Product Description
- Table 190: Asanté Rapid HIV-1 Recency (or Incidence) Assay - Product Status 6
- Table 191: Asanté Rapid HIV-1 Recency (or Incidence) Assay - Product Description 6
- Table 192: Sensible Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 7
- Table 193: Point-Of-Care Test - HIV - Product Status 7
- Table 194: Point-Of-Care Test - HIV - Product Description 7
- Table 195: Senzo Inc Pipeline Products & Ongoing Clinical Trials Overview 8
- Table 196: Amplified Lateral Flow Test - HIV - Product Status 8
- Table 197: Amplified Lateral Flow Test - HIV - Product Description 8
- Table 198: TheoremDx Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 199: Rapid Diagnostic Test - HIV - Product Status(TheoremDx Inc)
- Table 200: Rapid Diagnostic Test - HIV - Product Description(TheoremDx Inc)
- Table 201: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
- Table 202: HIV Self-Test Kit - Product Status
- Table 203: HIV Self-Test Kit - Product Description
- Table 204: TrinScreen HIV - Product Status
- Table 205: TrinScreen HIV - Product Description
- Table 206: University of Connecticut Pipeline Products & Ongoing Clinical Trials Overview
- Table 207: AIOD-CRISPR Assay - HIV - Product Status
- Table 208: AIOD-CRISPR Assay - HIV - Product Description
- Table 209: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
- Table 210: Lateral Flow Assay - HIV-1 - Product Status
- Table 211: Lateral Flow Assay - HIV-1 - Product Description
- Table 212: UrSure Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 213: PrEP Adherence Test - HIV - Product Status
- Table 214: PrEP Adherence Test - HIV - Product Description
- Table 215: Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- Table 216: RT CPA HIV-1 Viral Load Test - Product Status
- Table 217: RT CPA HIV-1 Viral Load Test - Product Description
- Table 218: Virax Biolabs Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 6
- Table 219: Virax Immune T-Cell Test - HIV - Product Status 6
- Table 220: Virax Immune T-Cell Test - HIV - Product Description 6
- Table 221: Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 7
- Table 222: EOSCAPE HIV-1 RNA Viral Load Test - Product Status 7
- Table 223: EOSCAPE HIV-1 RNA Viral Load Test - Product Description 7
- Table 224: EOSCAPE-HIV RNA PLUS - Product Status 8
- Table 225: EOSCAPE-HIV RNA PLUS - Product Description 8
- Table 226: Yaathum Biotech Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 9
- Table 227: Rapid Diagnostic Test - HIV - Product Status(Yaathum Biotech Pvt Ltd) 9
- Table 228: Rapid Diagnostic Test - HIV - Product Description(Yaathum Biotech Pvt Ltd) 9
- Table 229: Glossary 6
- 2.2 List of Figures
- Figure 1: HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
- Figure 2: HIV Point of care (POC) Tests - Pipeline Products by Territory
- Figure 3: HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
- Figure 4: HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
- Figure 5: HIV Point of care (POC) Tests - Ongoing Clinical Trials
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.